Title

Individual and composite study endpoints: separating the wheat from the chaff

UMMS Affiliation

Department of Quantitative Health Sciences; Meyers Primary Care Institute; Department of Medicine, Division of Cardiovascular Medicine

Publication Date

5-2014

Document Type

Article

Subjects

*Clinical Trials as Topic; Cost-Benefit Analysis; *Endpoint Determination; Humans; *Outcome Assessment (Health Care); Prospective Studies; *Research Design; Sample Size; Treatment Outcome

Disciplines

Clinical Epidemiology | Epidemiology | Health Services Research | Translational Medical Research

Abstract

We provide an overview of the individual and combined clinical endpoints and patient-reported outcomes typically used in clinical trials and prospective epidemiological investigations. We discuss the strengths and limitations associated with the utilization of aggregated study endpoints and surrogate measures of important clinical endpoints and patient-centered outcomes. We hope that the points raised in this overview will lead to the collection of clinically rich, relevant, measurable, and cost-efficient study outcomes.

Keywords

UMCCTS funding

DOI of Published Version

10.1016/j.amjmed.2014.01.011

Source

Goldberg R, Gore JM, Barton B, Gurwitz J. Individual and composite study endpoints: separating the wheat from the chaff. Am J Med. 2014 May;127(5):379-84. doi: 10.1016/j.amjmed.2014.01.011.

Journal/Book/Conference Title

The American journal of medicine

Related Resources

Link to Article in PubMed

PubMed ID

24486289

Share

COinS